At the 2015 Patient-Centered Oncology Care meeting, Julie M. Vose, MD, MBA, FASCO, president of the American Society of Clinical Oncology, gave the keynote speech and discussed the burden facing providers today to reach the goal of the triple aim.
Providing individualized care may be what many physicians went to medical school for, but the reality today is that there is a growing burden of administration and increasingly scarce time available to spend with patients, especially those who have complex illnesses like cancer.
So how does the healthcare industry effect change needed to achieve the triple aim of better care experience, improved health, and lower cost? In her keynote speech at the 2015 Patient-Centered Oncology Care meeting, Julie M. Vose, MD, MBA, FASCO, 2015-2016 president of the American Society of Clinical Oncology (ASCO), addressed the issue and what ASCO is doing.
Here are the slides from Vose's keynote speech.
And registration is open for the 2016 Annual Meeting of Patient-Centered Oncology Care, which will be held November 17-18 in Baltimore, Maryland. To learn more and register, visit the conference page.
Rare Autoimmune Disorder Linked With Increased Risk of Certain Skin Cancers
April 21st 2025The risk of some skin cancers, including squamous cell carcinoma, basal cell carcinoma, and non-melanoma skin cancer, was particularly heightened among patients with severe mucous membrane pemphigoid.
Read More
Exploring Racial, Ethnic Disparities in Cancer Care Prior Authorization Decisions
October 24th 2024On this episode of Managed Care Cast, we're talking with the author of a study published in the October 2024 issue of The American Journal of Managed Care® that explored prior authorization decisions in cancer care by race and ethnicity for commercially insured patients.
Listen
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Comparing Breast Cancer Treatment Outcomes Between Fee-for-Service and Medicare Advantage
April 4th 2025This study examined postdiagnosis breast cancer treatment outcomes for Medicare Advantage vs fee-for-service (FFS) Medicare in Ohio and found no significant differences overall but disparities for Black patients with FFS Medicare.
Read More